One previous study demonstrated that Bacteroides fragilis can trigger dendritic cell maturation and stimulate IL-12-dependent Th1 cell infiltration, thereby enhancing the anti-tumor effects of anti-CTLA-4 therapy [32]. Here, CTLA4 is linked to neoplasm.